A detailed history of Mosley Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Mosley Wealth Management holds 3,988 shares of ABBV stock, worth $700,213. This represents 0.51% of its overall portfolio holdings.

Number of Shares
3,988
Previous 3,735 6.77%
Holding current value
$700,213
Previous $641 Million 16.13%
% of portfolio
0.51%
Previous 0.55%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $41,451 - $50,430
253 Added 6.77%
3,988 $744 Million
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $14,395 - $16,810
-93 Reduced 2.43%
3,735 $641 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $12,465 - $14,203
-78 Reduced 2.0%
3,828 $697 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $537,465 - $605,312
3,906 New
3,906 $605 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mosley Wealth Management Portfolio

Follow Mosley Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mosley Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Mosley Wealth Management with notifications on news.